Document 2587 DOCN M94A2587 TI In vitro and in vivo activities of sparfloxacin against Chlamydia trachomatis. DT 9412 AU Nakata K; Matsui T; Miyazaki S; Arakawa S; Ishigami J; Kamidono S; Kobe University, Japan. SO Int Conf AIDS. 1994 Aug 7-12;10(1):270 (abstract no. PB0509). Unique Identifier : AIDSLINE ICA10/94369988 AB OBJECTIVE: To test the in vitro and in vivo activity of sparfloxacin, levofloxacin, tosufloxacin, clarithromycin and minocycline against C. trachomatis. METHODS: The susceptibility of C. trachomatis (25 strains) to sparfloxacin and the reference drugs was tested in vitro by inhibiting inclusion body formations in McCoy cells. The vivo antichlamydial activities of sparfloxacin and the reference drugs on C. trachomatis KN infection were examined in experimental leukopenic mice. Leukopenic mice were inoculated transurethrally with C. trachomatis, and the drugs were given then orally twice a day for 3 days. On day 5 of postinfection, the urinary bladder was removed and the mucous bladder membranes were rubbed off with swabs which were then cultured with McCoy cells. The absence of organisms in the urinary bladder was the sole endpoint of therapeutic success. RESULTS: The MICs (microgram/ml) of sparfloxacin, levofloxacin, tosufloxacin, clarithromycin, and minocycline against 25 clinical isolates were 0.025-0.05, 0.25-0.5, 0.063-0.125, 0.025-0.05, and 0.025-0.05, respectively. The ED50s (mg/kg) of sparfloxacin, levofloxacin, tosufloxacin, clarithromycin, and minocycline on urinary tract infection with C. trachomatis KN were 3.4, 13.8, 13.6, 15.6, and 4.2, respectively. CONCLUSIONS: Based on results, sparfloxacin is expected to be useful for treatment of C. trachomatis infection in humans. DE Animal Anti-Infective Agents, Fluoroquinolone/*PHARMACOLOGY Chlamydia trachomatis/*DRUG EFFECTS Clarithromycin/PHARMACOLOGY Comparative Study Dose-Response Relationship, Drug Mice Microbial Sensitivity Tests Minocycline/PHARMACOLOGY Naphthyridines/PHARMACOLOGY Quinolones/*PHARMACOLOGY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).